{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:30:42Z","timestamp":1790865042315,"version":"4.1.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/mph.0b013e3181ec0ae5","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T06:22:14Z","timestamp":1282198934000},"page":"e249-e258","source":"Crossref","is-referenced-by-count":27,"title":["Effect of Oral Arginine Supplementation on Exhaled Nitric Oxide Concentration in Sickle Cell Anemia and Acute Chest Syndrome"],"prefix":"10.1097","volume":"32","author":[{"given":"Kevin Joseph","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Kissoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Froyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210227","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V94.5.1555","article-title":"Sickle cell acute chest syndrome: pathogenesis and rationale for treatment","volume":"94","author":"Stuart","year":"1999","journal-title":"Blood"},{"key":"R2-14-20210227","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"R3-14-20210227","first-page":"47","article-title":"Sickle cell disease.","volume":"35-","author":"Buchanan","year":"2004","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"R4-14-20210227","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome","volume":"22","author":"Morris","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-14-20210227","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"R6-14-20210227","first-page":"498","article-title":"Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease","volume":"111","author":"Morris","year":"2000","journal-title":"Br J Haematol"},{"key":"R7-14-20210227","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<15::AID-AJH3>3.0.CO;2-P","article-title":"Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis","volume":"64","author":"Lopez","year":"2000","journal-title":"Am J Hematol"},{"key":"R8-14-20210227","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1553-2712.1996.tb03367.x","article-title":"Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis","volume":"3","author":"Lopez","year":"1996","journal-title":"Acad Emerg Med"},{"key":"R9-14-20210227","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2141.2003.04109.x","article-title":"L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department","volume":"120","author":"Lopez","year":"2003","journal-title":"Br J Haematol"},{"key":"R10-14-20210227","first-page":"165","article-title":"Inhaled nitric oxide for ARDS due to sickle cell disease","volume":"134","author":"Oppert","year":"2004","journal-title":"Swiss Med Wkly"},{"key":"R11-14-20210227","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000542-200609000-00028","article-title":"Inhaled nitric oxide for treatment of sickle cell stroke","volume":"105","author":"Montero-Huerta","year":"2006","journal-title":"Anesthesiology"},{"key":"R12-14-20210227","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1097\/00003246-199911000-00039","article-title":"Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent","volume":"27","author":"Sullivan","year":"1999","journal-title":"Crit Care Med"},{"key":"R13-14-20210227","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/00000542-199710000-00037","article-title":"Inhaled nitric oxide in sickle cell disease with acute chest syndrome","volume":"87","author":"Atz","year":"1997","journal-title":"Anesthesiology"},{"key":"R14-14-20210227","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.289.9.1136","article-title":"Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease","volume":"289","author":"Weiner","year":"2003","journal-title":"JAMA"},{"key":"R15-14-20210227","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajh.10284","article-title":"Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement","volume":"72","author":"Girgis","year":"2003","journal-title":"Am J Hematol"},{"key":"R16-14-20210227","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1164\/ajrccm.164.12.2012090","article-title":"Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome","volume":"164","author":"Sullivan","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-14-20210227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pbc.20872","article-title":"The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease","volume":"50","author":"Pawar","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R18-14-20210227","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"R19-14-20210227","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/ajrccm.162.2.9909105","article-title":"Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment","volume":"162","author":"Clini","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-14-20210227","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.52.12.1051","article-title":"Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension","volume":"52","author":"Kharitonov","year":"1997","journal-title":"Thorax"},{"key":"R21-14-20210227","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival","volume":"101","author":"Castro","year":"2003","journal-title":"Blood"},{"key":"R22-14-20210227","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00043426-200308000-00008","article-title":"Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease","volume":"25","author":"Morris","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R23-14-20210227","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","article-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease","volume":"116","author":"Gladwin","year":"2002","journal-title":"Br J Haematol"},{"issue":"suppl 3","key":"R24-14-20210227","first-page":"15","article-title":"Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults","volume":"34","author":"Charache","year":"1997","journal-title":"Semin Hematol"},{"key":"R25-14-20210227","first-page":"363","article-title":"Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results","volume":"93","author":"Waugh","year":"2001","journal-title":"J Natl Med Assoc"},{"key":"R26-14-20210227","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.2005.05625.x","article-title":"Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension","volume":"130","author":"Machado","year":"2005","journal-title":"Br J Haematol"},{"key":"R27-14-20210227","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/rccm.200208-967OC","article-title":"Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?","volume":"168","author":"Morris","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-14-20210227","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/thx.53.3.172","article-title":"Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects","volume":"53","author":"Sapienza","year":"1998","journal-title":"Thorax"},{"key":"R29-14-20210227","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/cs0880135","article-title":"L-arginine increases exhaled nitric oxide in normal human subjects","volume":"88","author":"Kharitonov","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"R30-14-20210227","first-page":"659","article-title":"REFERENCE spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"R31-14-20210227","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1172\/JCI1378","article-title":"Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism","volume":"101","author":"Dweik","year":"1998","journal-title":"J Clin Invest"},{"key":"R32-14-20210227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0034-5687(98)00033-4","article-title":"A significant proportion of exhaled nitric oxide arises in large airways in normal subjects","volume":"113","author":"Silkoff","year":"1998","journal-title":"Respir Physiol"},{"key":"R33-14-20210227","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1152\/jappl.2001.90.3.777","article-title":"Microscopic modeling of NO and S-nitrosoglutathione kinetics and transport in human airways","volume":"90","author":"Shin","year":"2001","journal-title":"J Appl Physiol"},{"key":"R34-14-20210227","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ppul.20582","article-title":"Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms","volume":"42","author":"Duckworth","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"R35-14-20210227","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00000441-199012000-00005","article-title":"Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine","volume":"300","author":"Enwonwu","year":"1990","journal-title":"Am J Med Sci"},{"key":"R36-14-20210227","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"},{"key":"R37-14-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00062752-200303000-00001","article-title":"An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy","volume":"10","author":"Reiter","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"R38-14-20210227","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"R39-14-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/niox.2001.0340","article-title":"Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase","volume":"5","author":"Flam","year":"2001","journal-title":"Nitric Oxide"},{"key":"R40-14-20210227","doi-asserted-by":"crossref","first-page":"31213","DOI":"10.1074\/jbc.272.50.31213","article-title":"A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the \u201carginine paradox\u201d","volume":"272","author":"McDonald","year":"1997","journal-title":"J Biol Chem"},{"key":"R41-14-20210227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10715760100300721","article-title":"Nitric oxide transport on sickle cell hemoglobin: where does it bind?","volume":"35","author":"Gladwin","year":"2001","journal-title":"Free Radic Res"},{"key":"R42-14-20210227","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1126\/science.276.5321.2034","article-title":"Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient","volume":"276","author":"Stamler","year":"1997","journal-title":"Science"},{"key":"R43-14-20210227","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1749-6632.2000.tb06201.x","article-title":"Reactive species in sickle cell disease","volume":"899","author":"Aslan","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R44-14-20210227","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.93.13.6770","article-title":"Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury","volume":"93","author":"Xia","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R45-14-20210227","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/ajrccm.149.2.7508323","article-title":"The biology of nitrogen oxides in the airways","volume":"149","author":"Gaston","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R46-14-20210227","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/thx.2004.029165","article-title":"Asthma in children with sickle cell disease and its association with acute chest syndrome","volume":"60","author":"Knight-Madden","year":"2005","journal-title":"Thorax"},{"key":"R47-14-20210227","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1067\/mpd.2001.111824","article-title":"Prevalence and reversibility of lower airway obstruction in children with sickle cell disease","volume":"138","author":"Koumbourlis","year":"2001","journal-title":"J Pediatr"},{"key":"R48-14-20210227","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-3476(97)70166-5","article-title":"Airway hyperreactivity in children with sickle cell disease","volume":"131","author":"Leong","year":"1997","journal-title":"J Pediatr"},{"key":"R49-14-20210227","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1164\/ajrccm.164.11.2104101","article-title":"Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research","volume":"164","author":"Minter","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R50-14-20210227","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-3476(05)83418-3","article-title":"Pulmonary function abnormalities in childhood sickle cell disease","volume":"122","author":"Pianosi","year":"1993","journal-title":"J Pediatr"},{"key":"R51-14-20210227","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00005792-198801000-00005","article-title":"Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure","volume":"67","author":"Powars","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"R52-14-20210227","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.98.12051124","article-title":"Pulmonary function in sickle cell disease with or without acute chest syndrome","volume":"12","author":"Santoli","year":"1998","journal-title":"Eur Respir J"},{"key":"R53-14-20210227","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pmj.79.933.384","article-title":"Pulmonary manifestations of sickle cell disease","volume":"79","author":"Siddiqui","year":"2003","journal-title":"Postgrad Med J"},{"key":"R54-14-20210227","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0889-8588(05)70400-7","article-title":"Pulmonary complications","volume":"10","author":"Vichinsky","year":"1996","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181ec0ae5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:40Z","timestamp":1786041520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201010000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181ec0ae5","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}